Evidence map›Paper›PMID 25747176›Full record

ArticleOral surgery, oral medicine, oral pathology and oral radiology2015

CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study.

Yau-Hua Yu, Jose Morales, Lei Feng, J Jack Lee, Adel K El-Naggar, Nadarajah Vigneswaran

Abstract read
In one paragraph

Article in Oral surgery, oral medicine, oral pathology and oral radiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 4 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 4 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. CD147 and glioma: a meta-analysis.Journal of neuro-oncology · 2017
    Pooled it
  4. Pooled it
  5. Article
  6. HPVTranslational oncology · 2021
    Review
  7. Article
  8. The stem cell markers expression CD44v6 and podoplanin in lip cancer: clinical significance.Virchows Archiv : an international journal of pathology · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yau-Hua YuDepartment of Diagnostic and Biomedical Sciences, The University of Texas School of Dentistry at Houston, Houston, TX; Department of Oral Medicine, Infection and Immunity, Division of Periodontology, Harvard School of Dental Medicine, Boston, MA.
Jose MoralesDepartment of Diagnostic and Biomedical Sciences, The University of Texas School of Dentistry at Houston, Houston, TX; Department of Orthodontics, Georgia Regents University, 1120 15th Street, GC-2144, Augusta, Georgia.
Lei FengDepartments of Biostatistics and Pathology, University of Texas MD Anderson Cancer Center, Houston, TX.
J Jack LeeDepartments of Biostatistics and Pathology, University of Texas MD Anderson Cancer Center, Houston, TX.
Adel K El-NaggarDepartments of Biostatistics and Pathology, University of Texas MD Anderson Cancer Center, Houston, TX.
Nadarajah VigneswaranDepartment of Diagnostic and Biomedical Sciences, The University of Texas School of Dentistry at Houston, Houston, TX. Electronic address: Nadarajah.vigneswaran@uth.tmc.edu.
The University of Texas MD Anderson Cancer Center · USAugusta University · USHarvard University · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cellsR01DE024392 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ANNAPRAGADA, ANANTH V, VIGNESWARAN, NADARAJAH · 2014 to 2017
$1.5M
Targeted Liposomal Delivery of CD147 siRNA to Murine Head and Neck Cancer ModelsR21DE019956 · NIDCR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI VIGNESWARAN, NADARAJAH · 2009 to 2010
$410k
NIDCR NIH HHS R01 DE024392NIDCR NIH HHS R21 DE019956
6 · The paper itself

Abstract

objectiveSquamous cell carcinoma of the oral tongue (SCCOT) exhibits high risk for recurrence and regional metastasis even after surgical resection. We assessed the clinicopathologic and prognostic significance of a group of functionally related biomarkers. STUDY

designWe used a tissue microarray consisting of SCCOT from 32 patients for this study. These patients were treated at the University of Texas MD Anderson Cancer Center from 1995 to 2008. Biomarker expression levels were examined by immunohistochemistry and graded semiquantitatively to determine their prognostic significance.

resultsCD147 and Tp63 expressions were significantly associated with a higher T stage and Ki-67 labeling index, as well as a shorter overall survival (OS) rate. Expression of Tp63 associated positively with poorly differentiated histology. There was significant association of Tp63 with the expression levels of CD147 and Glut-1. Glut-1 overexpression was marginally associated with a higher T stage. There was no prognostic significance of CD44 v6 expression in SCCOT.

conclusionSCCOT with CD147 overexpression in combination with high Ki-67 labeling index had poor OS. CD147 and Ki-67 overexpression is associated with aggressive disease with poor prognosis in SCCOT.

Indexed as

AdultAgedBasiginBiomarkers, TumorCarcinoma, Squamous CellFemaleGlucose Transporter Type 1HumansHyaluronan ReceptorsImmunohistochemistryKi-67 AntigenMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPrognosisBasiginBiomarkers, TumorBSG protein, humanCD44v6 antigenGlucose Transporter Type 1Hyaluronan ReceptorsKi-67 AntigenTP63 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID25747176
PMCPMC4397137
OpenAlexW2154807688

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.